Home > PS Ratio > CAPLIN POINT LABORATORIES

CAPLIN POINT LABORATORIES
PS (Price/Sales) Ratio

The Current P/S Ratio of CAPLIN POINT LABORATORIES is 9.95.

Share Price ₹2,397.1Dec 26,2024
Market Cap ₹18,217.6 Cr
Sales-TTM₹1,830.8 CrTTM-Consolidated Results
Price/Sales9.95xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for CAPLIN POINT LABORATORIES
Please provide your vote to see the results
CAPLIN POINT LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of CAPLIN POINT LABORATORIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of CAPLIN POINT LABORATORIES is calculated as :

Current Market Cap [ ₹18,217.6 Cr] as on Dec 26,2024

(/) Sales [ ₹1,830.8 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 9.95x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for CAPLIN POINT LABORATORIES , the investors are currently willing to pay '9.95 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of CAPLIN POINT LABORATORIES !

The chart below summarizes the trend in P/S Ratio of CAPLIN POINT LABORATORIES over the last five years.

Historical PS (Price/Sales) ratio chart of CAPLIN POINT LABORATORIES


PS Ratio Performance Analysis for CAPLIN POINT LABORATORIES

- CAPLIN POINT LABORATORIES 's latest p/e ratio is 9.95x.

- CAPLIN POINT LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.68x.

- CAPLIN POINT LABORATORIES 's operated at median p/e ratio of 3.09x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CAPLIN POINT LABORATORIES 's p/e ratio peaked in Mar2024 at 5.91x.

- CAPLIN POINT LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 2.47x.


How does CAPLIN POINT LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
CAPLIN POINT LABORATORIES 1,830.89.9518,217.6
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.78441,838.0
CIPLA LTD26,512.04.54120,270.0
DR REDDYS LABORATORIES LTD30,084.93.76113,077.0
ZYDUS LIFESCIENCES LTD21,483.54.4996,553.2
DIVIS LABORATORIES LTD8,614.018.12156,107.0
MANKIND PHARMA LTD11,018.010.91120,212.0
TORRENT PHARMACEUTICALS LTD11,225.010.30115,643.0
LUPIN LTD21,431.34.6499,532.1
AUROBINDO PHARMA LTD30,295.02.4172,945.8
ABBOTT INDIA LTD6,066.110.0360,844.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CAPLIN POINT LABORATORIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.41x
Max industry PS 18.12x
Median industry PS 8.78x
Average industry PS 7.99x



You may also like the below Video Courses